Production & Manufacturing
Manufacturing

Manufacturing News

View news from other Pharmaceutical sectors:
46-60 of 2321 results
Microbial contamination forces Sun Pharma to recall two lots of diabetes drug in US
By PBR Staff Writer
Sun Pharmaceutical Industries is voluntarily recalling two lots of diabetes drug Riomet in the US due to microbial contamination.
Production & Manufacturing > Manufacturing > News
Midatech secures manufacturing certification from Spanish regulatory authority
Midatech Pharma has received manufacturing certification from Spanish regulatory authority AEMPS.
Production & Manufacturing > Manufacturing > News
Fresenius Kabi to extend pharmaceutical manufacturing in North Carolina
The State of North Carolina and Fresenius Kabi have announced plans to expand the company's presence in Wilson, North Carolina.
Production & Manufacturing > Manufacturing > News
UK regulator accuses Concordia of overcharging NHS for thyroid drug
By PBR Staff Writer
The UK Competition and Markets Authority (CMA) has accused Canadian pharma company Concordia International of abusing its dominant position by increasing the price of a thyroid drug by about 6,000%.
Production & Manufacturing > Manufacturing > News
Cerecor to acquire TRx Pharmaceuticals
Cerecor has entered into an agreement to TRx Pharmaceuticals and its subsidiary Zylera Pharmaceuticals.
Production & Manufacturing > Manufacturing > News
Cardinal to divest drug distribution business in China to Shanghai Pharma
By PBR Staff Writer
Cardinal Health, an Ohio-based health care services company has signed a deal to divest its drug distribution business in China to Shanghai Pharmaceuticals (Shanghai Pharma) for $557m.
Production & Manufacturing > Manufacturing > News
Sumitomo to buy 20% stake in Sawai America for $211m
By PBR Staff Writer
Sumitomo Corporation of Americas (SCOA) has agreed to acquire 20% interest in Sawai Pharmaceutical’s US subsidiary Sawai America (SAI) for around $211m.
Production & Manufacturing > Manufacturing > News
Pfizer to exit from Chinese generic drug JV with Hisun
By PBR Staff Writer
Pfizer will exit from Hisun-Pfizer Pharmaceuticals, its Chinese joint venture (JV) for generic drugs, by divesting 49% stake to Sapphire I (HK) Holdings for an undisclosed price.
Production & Manufacturing > Manufacturing > News
Valeant to divest Sprout Pharmaceuticals to former owners
By PBR Staff Writer
Valeant Pharmaceuticals International's affiliate has agreed to divest its female libido-pill business Sprout Pharmaceuticals to a buyer associated with the latter’s former shareholders.
Production & Manufacturing > Manufacturing > News
Torrent to acquire Unichem's branded business of India and Nepal
Torrent Pharmaceuticals has entered into a definitive binding agreement with Unichem to acquire its branded business of India and Nepal (India business) for a consideration of Rs3600 crores.
Production & Manufacturing > Manufacturing > News
Celonic acquires Glycotope’s bio-manufacturing plant in Germany
Celonic, a privately owned CDMO based in Basel, Switzerland, has completed the acquisition of Glycotope’s bio-manufacturing facility in Heidelberg, Germany.
Production & Manufacturing > Manufacturing > News
FDA approves new dosing for Xarelto to reduce risk of VTE
Janssen Pharmaceuticals reported that 10mg once-daily dose of Xarelto (rivaroxaban) has been approved by the US Food and Drug Administration (FDA) for reducing the continued risk for recurrent venous thromboembolism (VTE) after at least six months of initial anticoagulation therapy.
Production & Manufacturing > Manufacturing > News
Lannett, Celgene sign settlement and license agreement related to Thalomid
Lannett has entered into a settlement and license agreement with Celgene, which resolves patent infringement litigation in the US related to Celgene's Thalomid.
Production & Manufacturing > Manufacturing > News
Novartis to buy nuclear medicine firm Advanced Accelerator Applications for $3.9bn
By PBR Staff Writer
Novartis has agreed to acquire French radiopharmaceutical company Advanced Accelerator Applications (AAA) for $3.9bn to strengthen its oncology presence.
Production & Manufacturing > Manufacturing > News
Teva loses Copaxone patent dispute case to Mylan in UK
By PBR Staff Writer
The UK High Court of Justice has given a decision in favor of Mylan and Synthon over their dispute concerning the patent of Teva Phamaceutical Industries’ multiple sclerosis (MS) treatment Copaxone which was ruled to be invalid due to obviousness.
Production & Manufacturing > Manufacturing > News
46-60 of 2321 results